Treatment of participants with positive cancer for HRRm or HRD. research hub

A Phase 2 Study of Olaparib Monotherapy in Participants with Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer

This study is testing a drug called Olaparib for people with advanced cancer that has specific genetic changes (HRRm or HRD positive). Researchers want to see if the drug can shrink tumours, if it's safe, and how long people respond to it.